The 2014–16 Ebola virus disease outbreak in west Africa was an unprecedented crisis that exposed weaknesses in health systems, outbreak response, and research. Poor preparedness caused delays in initiating research and publishing results. It is important to examine what happened and to learn lessons to improve in the future. Amanda Rojek and colleagues¹ examined clinical research done during the epidemic and found 11 treatment trials registered with ClinicalTrials.gov or the ISRCTN registry, of which six are now published (one soon after the Review by Rojek and colleagues was published).

中文翻译：

---

埃博拉病毒病治疗试验的启动和发表时间滞后

2014-16 年在西非爆发的埃博拉病毒病是一场史无前例的危机，暴露了卫生系统、疫情应对和研究方面的弱点。准备不足导致启动研究和发表结果的延误。重要的是要检查所发生的事情并吸取教训以在未来改进。Amanda Rojek 及其同事¹检查了流行期间进行的临床研究，发现在ClinicalTrials.gov或 ISRCTN 注册中心注册的 11 项治疗试验，其中 6 项现已发表（一项在 Rojek 及其同事的评论发表后不久）。